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P27Kip1, also known as Cyclin-dependent kinase inhibitor 1B, is an important check-point protein in the
cell cycle. It has been identiﬁed that although as a tumor suppressor, P27Kip1 is expressed in different
cancer cell types, which shows the therapeutic potential in tumor genesis. In this study, we examined the
upstream regulatory mechanism of P27Kip1 at the microRNA (miRNA) level in gastric carcinogenesis. We
used bioinformatics to predict that microRNA-200c (miR-200c) might be a direct upstream regulator of
P27Kip1. It was also veriﬁed in gastric epithelial-derived cell lines that overexpression of miR-200c sig-
niﬁcantly inhibited the expression levels of P27Kip1, whereas knockdown of miR-200c promoted P27Kip1
expression in AGS and BGC-823 cells. Furthermore, we identiﬁed the direct binding of miR-200c on the
P27Kip1 3′ -UTR sequence by luciferase assay. MiR-200c could enhance the colony formation of cells by
repressing P27Kip1 expression. In addition, the negative correlation between P27Kip1 and miR-200c in
human gastric cancer tissues and matched normal tissues further supported the tumor-promoting action
of miR-200c in vivo. Our ﬁnding suggested that miR-200c directly regulates the expression of P27Kip1 and
promotes cell growth in gastric cancer as an oncogene, which may provide new clues to treatment.
& 2016 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Gastric cancer is one of the most common and aggressive forms
in China [1]. Patients with gastric cancer are often given a poor
prognosis due to the difﬁculty of early diagnosis with highly
growth and high rate of recurrence [2,3].
It has been suggested that the abnormal expression of check
point genes can always be found in tumorgenesis, including TP53,
P27Kip1, P21Cip2, P16Ink1 and C-Myc [4–8]. P27Kip1, also known as
Cyclin-dependent kinase inhibitor 1B, binds to and prevents the
activation of cyclin E-CDK2 or cyclin D-CDK4 complexes, and thus
controls the cell cycle progression at G1 stage [9]. It is always
thought the inhibitor of cell cycle with a tumor suppressor [10,11].
In cancers it is often inactivated via impaired synthesis, ac-
celerated degradation, or mislocalization [12]. We previously re-
ported that FoxM1, the main positive regulator of cell cycle, canB.V. This is an open access article u
s article.regulate gastric cancer cells proliferation and senescence through
inhibition of P27Kip1 [13,14]. These observations support that
P27Kip1 is strongly negatively correlated with gastric carcinogen-
esis. It is important to better understand the regulation of P27Kip1
expression in tumorgenesis for anti-cancer therapy.
Currently, microRNAs (miRNAs) has been thought one of the
most important regulators in tumorgeneis [15–18]. MiRNAs are the
small non- translated RNA molecules with approximately 18–24
nucleotides in length. Every miRNA can directly bind to the com-
plementary sequence on the 3′-untranslated region (3′-UTR) of
many possible target mRNAs, which thus regulates the genes ex-
pression by post-transcriptional gene silencing, producing se-
quence speciﬁc mRNA cleavage, or translational repression [19,20].
MiRNAs can be the tumor suppressors or oncogenes which are
determined by the functions of their target genes [21,22]. There
are only a few research on the miRNAs regulation on P27Kip1 ex-
pression in tumorgenesis, including miR-221/222 [23,24]. We still
need more evidence on speciﬁc miRNA regulation on P27Kip1 and
its function in gastric carcinoma.
In this study, we demonstrated that miR-200c is an oncogene in
gastric carcinoma which can directly inhibit the expression ofnder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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to explore the relationship between miR-200c and P27Kip1 in
gastric carcinoma. We propose that antagomiRNAs of miR-200c
might be the potential for an anti-cancer therapy by reactivation of
P27Kip1.Table 1
Association of miR-200c and p27 expression in human gastric cancer tissues.
Category No. of patients miR-200c P27
high low P high low P
Age 40.05 40.05
o 60 years 6 4 2 1 5
Z60 years 9 6 3 4 5
Sex 40.05 40.05
Male 9 6 3 3 6
Female 6 4 2 2 4
Differentiation 40.05 40.05
Well 5 4 1 2 3
Poor 10 6 4 3 7
Tumor size 40.05 40.05
r5 cm 8 5 3 3 5
45 cm 7 5 2 2 52. Materials and methods
2.1. Cell lines and culture
The gastric epithelial-derived cancer cell lines AGS and BGC-
823 were obtained from the cell repository for Academia Sinica
(Shanghai). AGS cells were grown in Ham’s F12 (Gibco, USA). BGC-
823 cells were grown in RPMI1640 medium (Gibco, USA). The
medium was supplemented with 10% fetal bovine serum (Gibco,
USA). Both the cell lines were incubated in a humidiﬁed atmo-
sphere containing 5% CO2 at 37 °C.
2.2. RNA extraction and QRT-PCR
Total RNA was extracted by use of Trizol reagent (Invitrogen,
USA). For qRT-PCR of P27Kip1, total RNA was reverse transcribed by
use of the RevertAid First Strand cDNA synthesis Kit (Fermentas,
Canada). Real-time PCR was involved by the SUBY Green mixture
(Takara, Japan) with the Biorad Sequence Detection System. Gene
expression was normalized to that of β-actin. Results were calcu-
lated by the 2-ΔΔCt method. The level of mature miR-200c ex-
pression was analyzed by TaqMan miRNA Assay (Applied Biosys-
tems). cDNAwas synthesized from total RNA samples by use of the
TaqMan miRNA Reverse Transcription Kit and speciﬁc stem-loop
reverse transcription primers. Real-time PCR involved TaqMan
miRNA Assay primers with the TaqMan Universal PCR Master Mix.
The reactions were run in the Biorad Sequence Detect System. The
relative level of miRNA expression was normalized to that of U6
small noncoding RNA and the fold change for miRNA was calcu-
lated by the 2-ΔΔCt method. The primer sequences for p27Kip1, 5′-
ATGTCAAACGTGCGAGTGTCTAA-3′, and antisense, 5′-TTACGTTT-
GACGTCTTCTGAGG-3′, and β-actin, sense, 5‘-AGTTGCGTTA-
CACCCTTTCTTG-3′, and antisense, 5‘- CACCTTCACCGTTCCAGTTTT-
3′.
2.3. Western blotting
The protein level of P27Kip1 was determined by Western blot-
ting which was normalized by β-actin. In brief, the cells were lysed
in RIPA buffer. Then the lysate was spun down and the supernatant
was harvested. The concentration of the proteins was detected by
BCA assay. Equal amounts of proteins were separated by SDS
polyacrylamide gels and transferred onto membranes (Millipore),
which were blocked with 5% non-fat milk protein for 1 h, then
incubated with primary antibodies overnight at 4 °C. The anti-
bodies used were for P27Kip1 (1:300, Santa Cruz Biotechnology)
and β-actin (1:5,000, Sigma). The secondary antibodies were
horseradish peroxidase-conjugated goat-anti-rabbit IgG (1:5,000,
Santa Cruz Biotechnology). Immune complexes were detected by
use of the Chemiluminescent HRP Substrate Kit (Millipore).
2.4. Luciferase assay
The mimics and the inhibitor of miR-220c were purchased from
Ruibo (Guangzhou, China). The special fragment of the P27Kip1 3′-
UTR containing the miR-200c predicted target sites was synthe-
sized by Invitrogen (USA). Then the fragment was cloned into the
multiple cloning sites of the luciferase reporter pMIR-REPOTR
(Applied Biosystems, USA), designated as pMIR-REPORT-P27-3′-UTR, which was also used in PCR to generate pMIR-REPORT-P27-
3′-UTRmut plasmid with mutation of the binding sites on the 3′-
UTR of P27Kip1. For the transfection of the palsmids, cells were
seeded into 6-well plates (3105 cells/well) for 18–24 h. Then the
plasmids were transfected by the use of Lipofectamine 3000 (In-
vitrogen, USA). To examine the direct conjugation of miR-200c to
the 3′-UTR of P27Kip1, pMIR-REPORT-P27-3′-UTR and pMIR-RE-
PORT-P27-3′-UTRmut were co-transfected into AGS cells with
miR-200c mimics. pMIR-REPORT β-gal plasmid was used as a
negative control. Luciferase activity in the cell lysates was de-
termined by a single luciferase reporter assay (Promega, USA) 48 h
after transfection, and target promoter-driven ﬁreﬂy luciferase
activity was normalized to that of β-gal.
2.5. Clone formation assay
BGC-823 cells were incubated in 6-well plates for 18–24 h,
which were transfected with the corresponding mimics/inhibitor
for 48 h. Single cells were seeded on 6-well plates (300 cells/well).
After 10 days of incubation, plates were stained with Giemsa for
20 min. The number of colonies with more than 50 cells was
counted.
2.6. Patients and tissue specimens
Resected pairs of cancer tissue and distal normal gastric tissue
(45 cm from the margin of the tumor) from 15 patients with
gastric cancer were harvested during surgery at Qilu Hospital of
Shandong University 2014–2015. None of the patients had received
adjuvant chemotherapy before surgery. The diagnosis of gastric
cancer was histopathologically conﬁrmed. The general information
for patients is in Table 1. The study was approved by the ethics
committee of Shandong University School of Medicine.
2.7. Immunohistochemistry
The expression of P27Kip1 in human species was determined by
Immunohistochemistry. Resected tissue pairs were embedded
with parafﬁn and sliced into 5- mm pieces, which were depar-
afﬁnized and dehydrated with xylene and a graded series of al-
cohol. Antigen retrieval was treated in 0.1 M citrate buffer at pH
6.0 with heating. Then 3% H2O2 was used to block the endogenous
peroxidase activity. The slides were incubated with goat serum for
30 min, then with rabbit anti-human P27Kip1 (Santa Cruz, USA)
overnight at 4 °C. The results were detected with Diaminobenzi-
dine (DAB) staining (Vector Laboratories, USA) which were calcu-
lated with the microscope images (Olympus BX60, Tokyo, Japan).
Fig. 1. MiR-200c downregulated the expression of P27Kip1 in gastric cancer cell lines. QRT-PCR analyses of (A) miR-200c and (B) P27Kip1 mRNA level in control and miR-200c
mimics-transfected AGS, BGC-823 cell lines after 48 h. *Po0.05 and **Po0.01. (C) miR-200c and (D) P27Kip1 mRNA level in control and miR-200c inhibitors-transfected AGS,
BGC-823 cell lines after 48 h. *Po0.05 and **Po0.01. (E)Western blot analyses of P27Kip1 protein levels in gastric cancer cells treated with control and miR-200c mimics or
inhibitors. (F,G) Western blot analyses of P27Kip1 protein levels. *Po0.05 and **Po0.01. Data are mean 7 SEM of 3 independent experiments.
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Quantitative data are expressed as mean 7 SEM. Statistical
analysis was in the use of SPSS 15.0 (SPSS, Inc., Chicago, IL) by two-
tailed Student’s t-test. Statistical signiﬁcance was set at Po0.05.3. Results
MiR-200c downregulated the expression of P27Kip1 at the
protein level in gastric cancer cell lines.
The bioinformatics analysis with miRanda (http://www.micro
rna.org/microrna), TargetScan (http://www.targetscan.org), and
miRBase (http://www.mirbase.org) predicted P27Kip1 as an down-
stream target of miR-200c which could directly bind to the 3′-UTR
of P27Kip1. To determine the correlation between miR-200c and
P27Kip1 mRNA expression level, we transfected the miR-200c mi-
mics into AGS and BGC-823 cells for 48 h. The high expression of
miR-200c was detected by QRT-PCR (Fig. 1A), which repressed the
mRNA level of P27Kip1 without signiﬁcant difference (Fig. 1B). Si-
milarly, the transfection of miR-200c inhibitor (Fig. 1C) also did not
obviously increase the mRNA expression of P27Kip1 (Fig. 1D). Then
Western blotting was checked to determine the effect of miR-200c
on the expression of P27Kip1 protein. The results showed that with
miR-200c overexpression, the P27Kip1 protein level decreased.
While with the inhibition of miR-200c, the P27Kip1 protein level
recovered to a higher level (Fig. 1E, F and G). Therefore, miR-200c
inhibited P27Kip1 expression in the gastric cancer cells by de-
grading the protein level of P27Kip1.
3.1. P27Kip1 is the direct target of miR-200c
The complementary sequence of miR-200c was found on the
3′-UTR site of P27Kip1 (Fig. 2A). Then the direct regulation of miR-
200c on P27Kip1 expression by the binding of the special 3′-UTR
site was determined by luciferase report assay. AGS cells were
cotransfected with miR-200c mimics and P27Kip1 wild-type or
mutant-type 3′-UTR plasmids. Cotransfection of miR-200c andFig. 2. P27Kip1 is the direct target of miR-200c. (A) The wild sequence on 3′-UTR of
P27Kip1 that could be bound by miR-200c and the corresponding mutant sequence.
(B) Luciferase activity assay with pMIR-REPORT-p27-3′-UTR and pMIR-REPORT-
p27-3′-UTR mutant co-transfected with miR-200c mimics or the negative control in
gastric cancer cells for 48 h. *Po0.05 vs. con. Data are mean 7 SEM of 3 in-
dependent experiments.wild-type 3′-UTR plasmid reduced the luciferase activity by ap-
proximately 60% relative to the control, whereas mutant 3′-UTR
cotransfection almost restored the luciferase activity (Fig. 2B).
Thus, miR-200c directly targeted the binding site located at
P27Kip1 3′-UTR and P27Kip1 is one of direct targets of miR-200c.
3.2. MiR-200c was involved in the proliferation of gastric cancer cells
Colony formation assay in BGC-823 cells revealed that the ex-
pression level of miR-200c truly affected the proliferation of gas-
tric cancer cells (Fig. 3A). The enforced expression of miR-200c
enhanced the clone formation of cells, while the knockdown of
miR-200c signiﬁcantly inhibited the number of colonies (Fig. 3B).
Thus, miR-200c could work as an oncogene in human gastric
cancer cells to activate cell proliferation.
3.3. MiR-200c expression was enhanced in human primary gastric
cancer
We determined the expression of miR-200c in human primary
gastric cancer specimens and matched normal tissues from 15
patients. HE staining showed the pathology of the samples
(Fig. 4A). QRT-PCR and IHC results showed that P27Kip1 protein
expression was inhibited in human gastric cancer specimens
which was the same as the research before (Fig. 4A, B and C). At
the same time, the level of miR-200c expression was enhanced in
human gastric cancer samples (Fig. 4B), which supported the on-
cogenetic role of miR-200c in vitro. Therefore, miR-200c and
P27Kip1 might be negative covalent in vivo (Fig. 4D). We found no
association of miR-200c or P27Kip1 expression and patient age,
gender or tumor size (Table 1).4. Discussion
In this study, we showed that miR-200c played an oncogenetic
role in human gastric carcinogenesis by directly downregulated
the expression of P27Kip1 and promoted the gastric cancer cell
proliferation.
Gastric cancer (GC) is one of the most common human malig-
nant diseases and the second leading cause of tumor-related
deaths worldwide [1,2]. The incidence and mortality rate are
particularly high in eastern Asia [3]. Despite recent advances in
surgical techniques and adjuvant therapy after surgery, the 5-year
survival rate is still low [25]. Carcinogenesis is a multi-factor,
multi-phase and long-term interaction process on malignant
transformation of normal cells. In this process, the abnormal reg-
ulation of cell cycle is involved in all the stages [26]. In previous
studies, we have identiﬁed P27Kip1 is an important target which
could be regulated by different factors in the proliferation of gas-
tric cancer cells, including H. pylori infection, the escape of cancer
cells senescence, epigenetics, et al. [13,14,27]. We also ﬁnd that
P27Kip1 can express in different cancer cell lines, which means it
might be a valuable target for the diagnosis and treatment of
gastric cancer.
In most cancers, reduced levels of P27Kip1 are correlated with
increased tumor size, increased tumor grade, and a higher pro-
pensity for metastasis [28]. There might be different mechanisms
by which levels of P27Kip1 are regulated in different types of
cancers. The expression level of P27Kip1 can be regulated from the
different steps of gene expression, such as transcription, transla-
tion and proteolysis [29]. P27Kip1 can also be regulated by chan-
ging its subcellular location [30]. Both mechanisms act to reduce
the inhibition effect of P27Kip1 on the cell cycle, allowing for the
activation of Cdk1 and Cdk2, which can begin the process of the
cell cycle. We have identiﬁed that FoxM1 can inhibit the promoter
Fig. 3. MiR-200c was involved in the proliferation of gastric cancer cells. (A) Colony formation ability in gastric cancer cells with overexpression and knockdown of miR-200c
and (B) quantiﬁcation. *Po0.05. Data are mean 7 SEM of 3 independent experiments.
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P27Kip1 levels can also be moderated at the post transcriptional
level, it has been proposed that P27Kip1 may be regulated by
miRNAs.
MiRNAs have recently been discovered as one of the crucial
players in gastric carcinogenesis through posttranscriptional reg-
ulation of tumor suppressor and oncogenes [31–33]. A substantial
number of deregulated miRNAs have been revealed in gastric
cancer and the biological signiﬁcance of those miRNAs has been
conﬁrmed in multiple functional experiments. Only a fewresearches focus on the cell cycle inhibitors. In this study, we ﬁrst
predicted miR-200c as the up-stream regulator of P27Kip1 by
bioinformatics. Then the negative regulative effect of miR-200c
was determined in gastric cancer cell lines only at the translational
level, which means that miR-200c does not affect the P27Kip1
mRNA cleavage, but only repressed P27Kip1 translation. Luciferase
assay further suggested that P27Kip1 was the direct target of miR-
200c. The oncogenetic role of miR-200c was identiﬁed by the in-
crease of clone number with the overexpression of miR-200c in
gastric cancer cells. The higher level of miR-200c and reduced
Fig. 4. MiR-200c expression was enhanced in human primary gastric cancer. (A) HE staining and Immunohistochemical staining of expression of P27Kip1 in human normal
(left panel) and cancerous (right panel) gastric tissues. (B) Percentage positive cells by immunohistochemistry for P27Kip1 in human normal and cancerous gastric tissues.
**Po0.01. (C) QRT-PCR analyses of miR-200c and P27Kip1 mRNA in normal and cancerous human gastric tissues. *Po0.05. (D) Correlation of miR-200c and P27Kip1 levels in
human gastric cancer tissues after standardization with matched normal tissues. Data are mean 7 SEM of 3 independent experiments.
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proved their negative correlation in vivo. P27Kip1 has been showed
prognostic value in ovarian cancer in which P27Kip1 negative tu-
mors progressed in 23 months compared to 85 months in P27Kip1
positive tumors [19]. Similar studies have correlated low levels of
p27 with a worse prognosis in breast cancer [20]. The correlations
were also observed in patients with non-small cell lung cancer,
colorectal cancer, and prostate cancer [21–23]. So P27Kip1 can also
be correlated with treatment response and work as a therapeutictarget in cancer. In this study, we also identiﬁed the inhibition of
P27Kip1 expression in gastric carcinoma with the negative control
of miR-200c. The antagomiRs of miR-200c that can block the ac-
tivity of the miR-200c and allow for P27Kip1 cell grow inhibition to
take place might be a new way for gastric cancer treatment.
In summary, our results showed that miR-200c, which could
negatively regulate the expression of P27Kip1, was an important
oncogene involved in the cell proliferation of gastric cancer. These
ﬁndings may provide further information miR-200c to be useful as
Y. Wang et al. / Biochemistry and Biophysics Reports 8 (2016) 227–233 233an anti-cancer therapeutic agent in gastric cancer.Acknowledgments
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